VIR FY 2022 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.6B+47.5% YoY

Gross Profit

$995M61.6% margin

Operating Income

$833M51.6% margin

Net Income

$516M31.9% margin

EPS (Diluted)

$3.83

Cash Flow

Operating Cash Flow

$1.7B

Free Cash Flow

$1.6B

Stock-Based Comp.

$102M

Balance Sheet

Total Assets

$2.8B

Total Liabilities

$724M

Stockholders' Equity

$2.1B

Cash & Equivalents

$849M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.1B	+47.5%
Gross Profit	$995M	$582M	+71.1%
Operating Income	$833M	$421M	+98.0%
Net Income	$516M	$529M	-2.4%